<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02762773</url>
  </required_header>
  <id_info>
    <org_study_id>UHCASEMC2</org_study_id>
    <nct_id>NCT02762773</nct_id>
  </id_info>
  <brief_title>Effect of Non-Dissection of the Inferior Rectus Sheath on Intraoperative Blood Loss</brief_title>
  <official_title>Does Avoiding Inferior Rectus Sheath Dissection Lead to Decreased Operative Blood Loss and Operating Time Without Increasing Delivery of Fetus in Primary Cesarean Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospitals Cleveland Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Martin Wieczorek</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Melissa March</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospitals Cleveland Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of non-dissecting the inferior rectus
      sheath during primary cesarean delivery on post-operative hemoglobin and post-operative pain
      control as measured by VAS score and opioid anesthesia use in the first 72 hours post-op.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Anticipated">June 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>post-operative hemoglobin</measure>
    <time_frame>24 hours</time_frame>
    <description>assessment of drop in hemoglobin post-operatively compared to pre-operative values</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>assessment of Visual Analog Scale (VAS) scores in first 72 hours</measure>
    <time_frame>72 hours</time_frame>
    <description>assessment of VAS scores and</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of total narcotic use, expressed as morphine equivalents</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Acute Blood Loss Anemia</condition>
  <condition>Postoperative Pain</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will undergo non-dissection of the inferior rectus sheath at time of primary cesarean delivery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will undergo standard practice which is dissection of the superior and inferior rectus sheath at time of cesarean delivery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>non-dissection of inferior rectus sheath</intervention_name>
    <description>Non-dissection of inferior rectus sheath</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>control</intervention_name>
    <description>Dissection of inferior and superior aspect of the rectus sheath</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  - Patients must be 18 years or older as well as willing and able to provide informed
             consent

          -  Patients undergoing a scheduled or non-scheduled, non-urgent or non-scheduled urgent
             (delivery within 30 minutes of decision for surgical delivery) Cesarean delivery
             between &gt;35 weeks gestational age,

          -  Patients who are expected to receive a Pfannenstiel incision

          -  Patients with viable singleton intra-uterine pregnancy

          -  Patients with fetus in cephalic presentation

        Exclusion Criteria:

          -  - Patients younger than 18 years,

          -  Patients unable or unwilling to provide informed consent,

          -  Patients who are illiterate,

          -  Patients who are non-English speaking or reading,

          -  Patients who are University Hospital employees

          -  Patients who are medical or nursing students at a school affiliated with University
             Hospital

          -  Multi-fetal gestations (&gt;1 intrauterine pregnancy),

          -  Patients with a BMI &gt;40 kg/m^2

          -  Patients with a suspected placenta accreta or placenta previa

          -  Patients with a prior Cesarean delivery

          -  Patient undergoing emergent cesarean delivery (delivery within 10 minutes of decision
             for surgical delivery)

          -  Patients who will require a vertical skin incision, Maylard or Cherney incisions

          -  Patients with a history of significant pelvic adhesive disease, as determined by prior
             operative reports

          -  Patients with fetus in non-cephalic presentation

          -  Patients with pre-gestational or gestational diabetes mellitus

          -  Patients with estimated fetal weight &gt;5000 grams

          -  Patients with estimated fetal weight &lt;10% for gestational age

          -  Patients with who require general anesthetic

          -  Patients who are on chronic pain medication

          -  Patients with a history of drug abuse
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Wieczorek, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospitals Cleveland Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Melissa March, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospitals Cleveland Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>CeCe Cheng, MD</last_name>
    <phone>8327520043</phone>
    <email>cece.cheng@uhhospitals.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cece Cheng</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CECE Cheng, MD</last_name>
      <phone>832-752-0043</phone>
      <email>cece.cheng@uhhospitals.org</email>
    </contact>
    <investigator>
      <last_name>CeCe Cheng, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Melissa March, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>May 3, 2016</study_first_submitted>
  <study_first_submitted_qc>May 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2016</study_first_posted>
  <last_update_submitted>December 17, 2018</last_update_submitted>
  <last_update_submitted_qc>December 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospitals Cleveland Medical Center</investigator_affiliation>
    <investigator_full_name>CeCe Cheng</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

